Protalix BioTherapeutics Overview

Protalix BioTherapeutics Gross Profit

Gross Profit analysis for PLX.

Quarterly Gross Profit

$29.62M

↑ 1432.49% YoY

As of Mar 31, 2026

Annual Gross Profit (TTM)

$43.91M

↑ 14.83% YoY

Trailing 12 months ending Mar 31, 2026

Average Gross Profit (Comparison Companies)

Gross Profit History

Gross Profit Comparison

Annual Gross Profit Growth Rate (%)

Annual Gross Profit Growth (Absolute)

Jump to metric

Total Revenue Cost of Revenue Gross Profit Research & Development Selling, General & Admin Operating Income Other Income Expense Net EBIT Income Tax Net Income Profit Margin